Global Gastrointestinal Diseases Therapeutics Market 2023-2027

Description

List of Tables

The gastrointestinal diseases therapeutics market is forecasted to grow by USD 17074.34 mn during 2022-2027, accelerating at a CAGR of 6.67% during the forecast period. The report on the gastrointestinal diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of gastrointestinal diseases, new gastrointestinal therapeutics product launches, and increasing demand for biologics and targeted therapies.

Technavio's gastrointestinal diseases therapeutics market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	6.02%
CAGR	6.67%
Incremental Value	$17,074.34mn

By Drug Class

Anti-inflammatory and immunosuppressors
Acid neutralizers
Others

By Type

Branded
Generics

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the availability of nutritional therapies as one of the prime reasons driving the gastrointestinal diseases therapeutics market growth during the next few years. Also, the emergence of microbiome-based therapies and an increase in self-medication coupled with home-based therapies will lead to sizable demand in the market.

The report on the gastrointestinal diseases therapeutics market covers the following areas:

Gastrointestinal diseases therapeutics market sizing
Gastrointestinal diseases therapeutics market forecast
Gastrointestinal diseases therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastrointestinal diseases therapeutics market vendors that include Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Boston Scientific Corp., Eisai Co. Ltd., Eli Lilly and Co., Evoke Pharma Inc., GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Novartis AG, Olympus Corp., Ovesco Endoscopy AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and UCB SA. Also, the gastrointestinal diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43343

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global gastrointestinal diseases therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global gastrointestinal diseases therapeutics market 2017 - 2021 ($ million)
4.2 Drug class Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Drug class Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Drug Class

6.1 Market segments
Exhibit 30: Chart on Drug Class - Market share 2022-2027 (%)
Exhibit 31: Data Table on Drug Class - Market share 2022-2027 (%)
6.2 Comparison by Drug Class
Exhibit 32: Chart on Comparison by Drug Class
Exhibit 33: Data Table on Comparison by Drug Class
6.3 Anti-inflammatory and immunosuppressors - Market size and forecast 2022-2027
Exhibit 34: Chart on Anti-inflammatory and immunosuppressors - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Anti-inflammatory and immunosuppressors - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Anti-inflammatory and immunosuppressors - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Anti-inflammatory and immunosuppressors - Year-over-year growth 2022-2027 (%)
6.4 Acid neutralizers - Market size and forecast 2022-2027
Exhibit 38: Chart on Acid neutralizers - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Acid neutralizers - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Acid neutralizers - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Acid neutralizers - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Drug Class
Exhibit 46: Market opportunity by Drug Class ($ million)
Exhibit 47: Data Table on Market opportunity by Drug Class ($ million)

7 Market Segmentation by Type

7.1 Market segments
Exhibit 48: Chart on Type - Market share 2022-2027 (%)
Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Branded - Market size and forecast 2022-2027
Exhibit 52: Chart on Branded - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Branded - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Branded - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Branded - Year-over-year growth 2022-2027 (%)
7.4 Generics - Market size and forecast 2022-2027
Exhibit 56: Chart on Generics - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Generics - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Generics - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Generics - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 60: Market opportunity by Type ($ million)
Exhibit 61: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Japan - Market size and forecast 2022-2027
Exhibit 87: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 France - Market size and forecast 2022-2027
Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 111: Abbott Laboratories - Overview
Exhibit 112: Abbott Laboratories - Business segments
Exhibit 113: Abbott Laboratories - Key news
Exhibit 114: Abbott Laboratories - Key offerings
Exhibit 115: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 116: AbbVie Inc. - Overview
Exhibit 117: AbbVie Inc. - Product / Service
Exhibit 118: AbbVie Inc. - Key news
Exhibit 119: AbbVie Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 120: AstraZeneca Plc - Overview
Exhibit 121: AstraZeneca Plc - Product / Service
Exhibit 122: AstraZeneca Plc - Key news
Exhibit 123: AstraZeneca Plc - Key offerings
12.6 Bausch Health Companies Inc.
Exhibit 124: Bausch Health Companies Inc. - Overview
Exhibit 125: Bausch Health Companies Inc. - Business segments
Exhibit 126: Bausch Health Companies Inc. - Key news
Exhibit 127: Bausch Health Companies Inc. - Key offerings
Exhibit 128: Bausch Health Companies Inc. - Segment focus
12.7 Bayer AG
Exhibit 129: Bayer AG - Overview
Exhibit 130: Bayer AG - Business segments
Exhibit 131: Bayer AG - Key news
Exhibit 132: Bayer AG - Key offerings
Exhibit 133: Bayer AG - Segment focus
12.8 Biogen Inc.
Exhibit 134: Biogen Inc. - Overview
Exhibit 135: Biogen Inc. - Product / Service
Exhibit 136: Biogen Inc. - Key offerings
12.9 Boehringer Ingelheim International GmbH
Exhibit 137: Boehringer Ingelheim International GmbH - Overview
Exhibit 138: Boehringer Ingelheim International GmbH - Business segments
Exhibit 139: Boehringer Ingelheim International GmbH - Key news
Exhibit 140: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 141: Boehringer Ingelheim International GmbH - Segment focus
12.10 Boston Scientific Corp.
Exhibit 142: Boston Scientific Corp. - Overview
Exhibit 143: Boston Scientific Corp. - Business segments
Exhibit 144: Boston Scientific Corp. - Key news
Exhibit 145: Boston Scientific Corp. - Key offerings
Exhibit 146: Boston Scientific Corp. - Segment focus
12.11 Eisai Co. Ltd.
Exhibit 147: Eisai Co. Ltd. - Overview
Exhibit 148: Eisai Co. Ltd. - Business segments
Exhibit 149: Eisai Co. Ltd. - Key offerings
Exhibit 150: Eisai Co. Ltd. - Segment focus
12.12 GlaxoSmithKline Plc
Exhibit 151: GlaxoSmithKline Plc - Overview
Exhibit 152: GlaxoSmithKline Plc - Business segments
Exhibit 153: GlaxoSmithKline Plc - Key news
Exhibit 154: GlaxoSmithKline Plc - Key offerings
Exhibit 155: GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson
Exhibit 156: Johnson and Johnson - Overview
Exhibit 157: Johnson and Johnson - Business segments
Exhibit 158: Johnson and Johnson - Key news
Exhibit 159: Johnson and Johnson - Key offerings
Exhibit 160: Johnson and Johnson - Segment focus
12.14 Merck and Co. Inc.
Exhibit 161: Merck and Co. Inc. - Overview
Exhibit 162: Merck and Co. Inc. - Business segments
Exhibit 163: Merck and Co. Inc. - Key news
Exhibit 164: Merck and Co. Inc. - Key offerings
Exhibit 165: Merck and Co. Inc. - Segment focus
12.15 Pfizer Inc.
Exhibit 166: Pfizer Inc. - Overview
Exhibit 167: Pfizer Inc. - Product / Service
Exhibit 168: Pfizer Inc. - Key news
Exhibit 169: Pfizer Inc. - Key offerings
12.16 Takeda Pharmaceutical Co. Ltd.
Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 UCB SA
Exhibit 174: UCB SA - Overview
Exhibit 175: UCB SA - Product / Service
Exhibit 176: UCB SA - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations